Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Alexis, Edelstein"'
Autor:
Jéromine Klingler, Shreyas Kowdle, Juan C. Bandres, Rozita Emami-Gorizi, Raymond A. Alvarez, Priyanka G. Rao, Fatima Amanat, Charles Gleason, Giulio Kleiner, Viviana Simon, Alexis Edelstein, Claudia Perandones, Chitra Upadhyay, Benhur Lee, Catarina E. Hioe
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionAntibodies against the SARS-CoV-2 spike protein are a critical immune determinant for protection against the virus. While virus neutralization is a key function of spike-specific antibodies, antibodies also mediate Fc-dependent activities
Externí odkaz:
https://doaj.org/article/decc1bd9a5024a729a8bf1a0e2ce7ea7
Autor:
Sabrina E. Vinzón, María V. Lopez, Eduardo G. A. Cafferata, Ariadna S. Soto, Paula M. Berguer, Luciana Vazquez, Leonora Nusblat, Andrea V. Pontoriero, Eduardo M. Belotti, Natalia R. Salvetti, Diego L. Viale, Ariel E. Vilardo, Martin M. Avaro, Estefanía Benedetti, Mara L. Russo, María E. Dattero, Mauricio Carobene, Maximiliano Sánchez-Lamas, Jimena Afonso, Mauro Heitrich, Alejandro E. Cristófalo, Lisandro H. Otero, Elsa G. Baumeister, Hugo H. Ortega, Alexis Edelstein, Osvaldo L. Podhajcer
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-15 (2023)
Abstract COVID-19 vaccines were originally designed based on the ancestral Spike protein, but immune escape of emergent Variants of Concern (VOC) jeopardized their efficacy, warranting variant-proof vaccines. Here, we used preclinical rodent models t
Externí odkaz:
https://doaj.org/article/ba99e3be03244ebfae597386425015da
Autor:
Satoshi Ikegame, Mohammed N. A. Siddiquey, Chuan-Tien Hung, Griffin Haas, Luca Brambilla, Kasopefoluwa Y. Oguntuyo, Shreyas Kowdle, Hsin-Ping Chiu, Christian S. Stevens, Ariel Esteban Vilardo, Alexis Edelstein, Claudia Perandones, Jeremy P. Kamil, Benhur Lee
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Here, the authors characterize the neutralization capacity of post-Sputnik V vaccination sera against SARS-CoV-2 variants of concern B.1.1.7 (alpha) and B.1.351 (beta), showing the latter to exhibit resistance to neutralization in vitro.
Externí odkaz:
https://doaj.org/article/0052d93aa3304d7589b1a88dc0956267
Autor:
Damian Emilio Berardi, Lizeth Ariza Bareño, Natalia Amigo, Luciana Cañonero, Maria de las Nieves Pelagatti, Andrea Nora Motter, María Agustina Taruselli, María Inés Díaz Bessone, Stefano Martin Cirigliano, Alexis Edelstein, María Giselle Peters, Miriam Diament, Alejandro Jorge Urtreger, Laura Beatriz Todaro
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
Abstract Breast cancer is the leading cause of cancer death among women worldwide. Blocking a single signaling pathway is often an ineffective therapy, especially in the case of aggressive or drug-resistant tumors. Since we have previously described
Externí odkaz:
https://doaj.org/article/01e93465ea7b4915836df1684987bcd4
Autor:
Rossana Elena Chahla, Rodrigo Hernán Tomas-Grau, Silvia Inés Cazorla, Diego Ploper, Esteban Vera Pingitore, Mónica Aguilar López, Patricia Aznar, María Elena Alcorta, Eva María del Mar Vélez, Agustín Stagnetto, César Luís Ávila, Carolina Maldonado-Galdeano, Sergio Benjamín Socias, Dar Heinze, Silvia Adriana Navarro, Conrado Juan Llapur, Dardo Costa, Isolina Flores, Alexis Edelstein, Shreyas Kowdle, Claudia Perandones, Benhur Lee, Gabriela Apfelbaum, Raúl Mostoslavsky, Gustavo Mostoslavsky, Gabriela Perdigón, Rosana Nieves Chehín
Publikováno v:
The Lancet Regional Health. Americas, Vol 6, Iss , Pp 100123- (2022)
Summary: Background: Gam-COVID-Vac (SPUTNIK V) has been granted emergency use authorization in 70 nations and has been administered to millions worldwide. However, there are very few peer-reviewed studies describing its effects. Independent reports r
Externí odkaz:
https://doaj.org/article/39faa4bf3a2e4467b06cf6cf6887b230
Autor:
Lorena Lewis, Elyse R. Nagle, Camila P Olivera, Carla Bellomo, Josefina Campos, JA Diaz, Constanza Anselmo, Valeria P. Martinez, Fernanda Pontoriero, Bonnie Dighero-Kemp, Jens H. Kuhn, Enzo Lavarra, Daniel Cisterna, Miriam I Burgos, Peter A. Larson, Ayelén A Iglesias, Mario Kaler, Beatriz López, Rocío Coelho, Daniel Oscar Alonso, Adolfo Rubinstein, Emiliano Biondo, Natalia Periolo, Jeffrey R. Kugelman, Heema Sharma, Unai Pérez-Sautu, Gustavo Palacios, Teresa Strella, Mariano Sanchez-Lockhart, Claudia Perandones, Alexis Edelstein, Catherine B. Pratt, Nicholas Di Paola, Joseph A. Chitty
Publikováno v:
New England Journal of Medicine
From November 2018 through February 2019, person-to-person transmission of Andes virus (ANDV) hantavirus pulmonary syndrome occurred in Chubut Province, Argentina, and resulted in 34 confirmed infections and 11 deaths. Understanding the genomic, epid
Autor:
Olga V Suárez, Gerardo R Cueto, Regino Cavia, Isabel E Gómez Villafañe, David N Bilenca, Alexis Edelstein, Paula Martínez, Sergio Miguel, Carla Bellomo, Karina Hodara, Paula J Padula, María Busch
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 98, Iss 6, Pp 727-732 (2003)
We studied hantavirus seroprevalence and virus variability in rodent populations in Diego Gaynor, northwest of Buenos Aires province, Argentina. Rodent samplings were conducted in railroads and cropfield borders in March and July 1999, September and
Externí odkaz:
https://doaj.org/article/13f3e33d88834618b559ef73beb75aca
Autor:
Hsin-Ping Chiu, Kasopefoluwa Y. Oguntuyo, Mohammed N. A. Siddiquey, Alexis Edelstein, Griffin Haas, Claudia Perandones, Shreyas Kowdle, Satoshi Ikegame, Luca Brambilla, Benhur Lee, Jeremy P. Kamil, Christian S. Stevens, Ariel Esteban Vilardo, Chuan-Tien Hung
Publikováno v:
Research Square
article-version (status) pre
article-version (number) 1
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
article-version (status) pre
article-version (number) 1
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected at least 180 million people since its identification as the cause of the current COVID-19 pandemic. The rapid pace of vaccine development has resulted in multiple vaccines alre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ed93619273d23de765fde6f0644b444
https://doi.org/10.1101/2021.03.31.21254660
https://doi.org/10.1101/2021.03.31.21254660
Autor:
Isolina Flores, Rossana Elena Chahla, Gabriela Perdigón, Rosana Chehín, Conrado Jose LLapur, Benhur Lee, Mónica Aguilar López, César Ávila, Dardo Costa, Esteban Vera Pingitore, Silvia Ines Cazorla, Patricia Aznar, Eva Maria del Mar Velez, Gabriela Apfelbaum, Raul Mostoslavsky, Gustavo Mostoslavsky, Alexis Edelstein, Diego Ploper, Aguístn Stagnetto, María Elena Alcorta, Silvia Adriana Navarro, Claudia Perandones, Carolina Maldonado Galdeano, Shreyas Kowdle, Sergio B. Socías, Rodrigo Hernán Tomás Grau, Dar Heinze
Publikováno v:
SSRN Electronic Journal.
Background: Gam-COVID-Vac, also known as SPUTNIK V, is the first COVID-19 vaccine registered, has emergency use authorization in 70 nations, and has been administered to millions worldwide. However, there are very few peer-reviewed studies describing
Autor:
Luciana Cañonero, Andrea Motter, María Agustina Taruselli, Maria de Las Nieves Pelagatti, Lizeth Ariza Bareño, Natalia Loreley Amigo, Miriam J. Diament, Stefano M. Cirigliano, María Giselle Peters, Alexis Edelstein, Laura B. Todaro, Damian E. Berardi, Alejandro J. Urtreger, María I. Díaz Bessone
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-17 (2021)
Breast cancer is the leading cause of cancer death among women worldwide. Blocking a single signaling pathway is often an ineffective therapy, especially in the case of aggressive or drug-resistant tumors. Since we have previously described the mecha